GO:0009265 2'-deoxyribonucleotide biosynthetic process: DNA Building Blocks, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009265 describes the chemical reactions and pathways that produce 2'-deoxyribonucleotides, the activated building blocks of DNA [1, 4].
• The term covers both de novo synthesis from small molecules and salvage of preformed deoxyribonucleosides into phosphorylated 2'-deoxyribonucleotides [1, 6].
• Enzymes such as ribonucleotide reductase, thymidylate synthase, and deoxyribonucleoside kinases are central to this process [1, 6].
• 2'-Deoxyribonucleotide pools must be balanced because imbalances cause mutations, replication stress, and cell death [1, 8].
• Modified 2'-deoxyribonucleotides are widely used as antiviral, anticancer, and polymerase-substrate research tools [2, 6].
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes in this pathway [1, 6].
Description
2'-Deoxyribonucleotide biosynthetic process (GO:0009265) is the biological process that generates 2'-deoxyribonucleotides, the phosphorylated deoxyribose-containing nucleotides that serve as the direct precursors for DNA synthesis [1, 4]. These molecules consist of a nitrogenous base linked to a 2'-deoxyribose sugar and esterified with one or more phosphate groups, and they are required for genome replication, repair, and mitochondrial DNA maintenance [1, 8]. Because DNA polymerases cannot synthesize DNA without an adequate and balanced supply of 2'-deoxyribonucleotides, this process is fundamental to cell proliferation and genome stability [1, 6]. Researchers study GO:0009265 because defects in deoxyribonucleotide production or salvage are linked to replication stress, mutagenesis, and sensitivity to anticancer and antiviral drugs [1, 8]. The pathway also provides the chemical framework for designing nucleotide analogs, including 2'-modified nucleotides used as polymerase substrates and therapeutic inhibitors [2, 6]. Understanding how cells synthesize and regulate 2'-deoxyribonucleotides therefore connects basic nucleotide biochemistry to cancer biology, infectious disease, and genome engineering [1, 6]. This article summarizes the definition, mechanism, key genes, disease links, and experimental models for GO:0009265, with a focus on how CRISPR-based cell models can be used to test causal roles of pathway components [1, 6].
2'-deoxyribonucleotide biosynthetic process At A Glance
| GO ID | GO:0009265 |
|---|---|
| GO term | 2'-deoxyribonucleotide biosynthetic process |
| Ontology | biological_process |
| Synonym | 2'-deoxyribonucleotide anabolism; 2'-deoxyribonucleotide biosynthesis; 2'-deoxyribonucleotide formation; 2'-deoxyribonucleotide synthesis |
| Major function | Production of phosphorylated 2'-deoxyribonucleotides for DNA replication, repair, and mitochondrial DNA synthesis [1, 4] |
| Substrates | Ribonucleotides, deoxyribonucleosides, and phosphate donors [1, 6] |
| Key enzymes | Ribonucleotide reductase, thymidylate synthase, deoxyribonucleoside kinases, nucleoside diphosphate kinases [1, 6] |
| Cellular location | Cytosol, mitochondria, and nucleus-associated nucleotide pools [1, 8] |
| Related process | DNA replication, nucleotide salvage, and nucleotide excision repair [1, 8] |
What Is GO:0009265?
In simple terms, GO:0009265 describes the set of biochemical reactions that build 2'-deoxyribonucleotides, the nucleotide units used to make DNA [1, 4]. According to the QuickGO definition, it is the chemical reactions and pathways resulting in the formation of a 2'-deoxyribonucleotide, a compound consisting of a 2'-deoxyribonucleoside (a base linked to a 2'-deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar [1, 4]. The term includes both de novo routes that assemble the deoxyribose-phosphate backbone and salvage routes that phosphorylate preformed deoxyribonucleosides [1, 6].
Why Is 2'-deoxyribonucleotide biosynthetic process Important in Cell Biology?
GO:0009265 is important because it supplies the activated precursors required for DNA synthesis and because its dysregulation directly affects genome stability, cell proliferation, and responses to nucleotide-targeting drugs [1, 8]. Cells must maintain balanced pools of dATP, dTTP, dGTP, and dCTP; imbalances can increase mutation rates and cause replication fork stalling [1, 8]. The pathway is also a major target of anticancer and antiviral therapies, and modified 2'-deoxyribonucleotides are essential tools for studying DNA polymerases and nucleic acid chemistry [2, 6].
• Provides dNTP precursors for DNA replication and repair [1, 4].
• Maintains mitochondrial DNA synthesis and mitochondrial function [1, 8].
• Controls mutation rates through balanced deoxyribonucleotide pools [1, 8].
• Determines sensitivity to anticancer nucleoside analogs [1, 6].
• Supports antiviral drug design targeting viral polymerases [2, 6].
• Enables chemical biology studies using 2'-modified nucleotides [2, 6].
• Links nucleotide metabolism to replication stress and cell cycle checkpoints [1, 8].
• Provides biomarkers such as oxidized 2'-deoxyribonucleotide adducts [4, 8].
• Informs CRISPR screens for metabolic vulnerabilities in cancer [1, 6].
• Guides design of polymerase substrates for synthetic biology [2, 6].
What Happens During 2'-deoxyribonucleotide biosynthetic process?
De novo synthesis from ribonucleotides
In simple terms: The cell first makes ribonucleotides and then converts them into deoxyribonucleotides.
In the de novo route, ribonucleoside diphosphates are reduced to their 2'-deoxy forms by ribonucleotide reductase, producing the four canonical deoxyribonucleotide building blocks needed for DNA synthesis [1, 6]. This step is rate-limiting and is tightly regulated to balance dNTP pools [1, 8]. The resulting 2'-deoxyribonucleotides are then phosphorylated to triphosphates by nucleoside diphosphate kinases and related enzymes [1, 6].
Salvage of deoxyribonucleosides
In simple terms: Instead of building from scratch, cells can recycle deoxyribonucleosides into nucleotides.
Salvage pathways phosphorylate preformed 2'-deoxyribonucleosides using deoxyribonucleoside kinases, allowing cells to recover nucleotides from extracellular or intracellular sources [1, 6]. This route is especially important in tissues with high nucleotide demand and in cells exposed to nucleoside analogs [1, 6]. Salvage enzymes also determine the activation of many antiviral and anticancer prodrugs [2, 6].
Thymidylate and pyrimidine deoxyribonucleotide formation
In simple terms: Thymine-containing DNA building blocks are made by a dedicated methylation step.
Thymidylate synthase converts dUMP to dTMP, which is then phosphorylated to dTTP for DNA synthesis [1, 6]. This reaction is a key node in pyrimidine deoxyribonucleotide biosynthesis and is targeted by antifolate and fluoropyrimidine drugs [1, 6]. Because dTTP is unique to DNA, its production is closely coordinated with DNA replication [1, 8].
Phosphorylation and pool maintenance
In simple terms: Enzymes add phosphate groups and keep the four DNA building blocks at the right levels.
Nucleoside monophosphate and diphosphate kinases sequentially phosphorylate 2'-deoxyribonucleotides to their di- and triphosphate forms [1, 6]. Feedback regulation and compartmentalization help maintain balanced dNTP pools, and imbalances can cause misincorporation and replication stress [1, 8]. Oxidized 2'-deoxyribonucleotide adducts can also form and are measured as markers of oxidative stress [4, 8].
Modified 2'-deoxyribonucleotide analogs
In simple terms: Chemists can make modified versions of these building blocks to study or inhibit DNA enzymes.
Synthetic 2'-modified deoxyribonucleotides, such as 2'-amino- and 2'-fluoro-2'-deoxyribonucleotides, can act as polymerase substrates or inhibitors and are used in nucleic acid therapeutics [2, 6]. C5-modified 2'-deoxyuridine and 2'-deoxycytidine triphosphates have been tested as substrates for DNA polymerases, showing how structural changes affect enzyme recognition. Such analogs are valuable for probing the specificity of enzymes involved in GO:0009265 [2, 6].
Key Genes Involved in GO:0009265 2'-deoxyribonucleotide biosynthetic process
The following genes and proteins are experimentally linked to 2'-deoxyribonucleotide biosynthesis, salvage, and related DNA precursor metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RRM1 | Ribonucleotide reductase subunit, reduces ribonucleotides to deoxyribonucleotides | Target for dNTP pool studies and anticancer drug response [1, 6] |
| RRM2 | Ribonucleotide reductase subunit, catalytic activity in de novo dNTP synthesis | Cell cycle regulation and replication stress models [1, 8] |
| TYMS | Thymidylate synthase, converts dUMP to dTMP | Fluoropyrimidine and antifolate sensitivity studies [1, 6] |
| DCK | Deoxycytidine kinase, phosphorylates deoxycytidine and analogs | Nucleoside analog activation and salvage research [1, 6] |
| TK1 | Thymidine kinase 1, salvage of thymidine to dTMP | Proliferation marker and nucleotide salvage studies [1, 6] |
| TK2 | Thymidine kinase 2, mitochondrial thymidine salvage | Mitochondrial DNA maintenance and dNTP pool studies [1, 8] |
| DGUOK | Deoxyguanosine kinase, mitochondrial purine deoxynucleoside salvage | Mitochondrial nucleotide metabolism research [1, 8] |
| NME1 | Nucleoside diphosphate kinase, phosphorylates dNDPs to dNTPs | dNTP pool and metastasis-related studies [1, 6] |
| NME2 | Nucleoside diphosphate kinase, dNTP synthesis and signaling | Nucleotide metabolism and cancer models [1, 6] |
| CMPK1 | UMP-CMP kinase, phosphorylates pyrimidine nucleotides | Pyrimidine deoxyribonucleotide synthesis studies [1, 6] |
| NT5C | Cytosolic 5'-nucleotidase, dephosphorylates nucleotides | Nucleotide pool balance and drug metabolism [1, 6] |
| SAMHD1 | Regulates dNTP pools and restricts viral replication | Innate immunity and dNTP pool research [1, 8] |
| GUK1 | Guanylate kinase, phosphorylates GMP to GDP | Purine nucleotide metabolism studies [1, 6] |
| PRPS1 | Phosphoribosyl pyrophosphate synthetase, supplies PRPP for nucleotide synthesis | Purine biosynthesis and disease models [1, 6] |
| ATIC | Bifunctional purine biosynthesis enzyme | Purine deoxyribonucleotide precursor studies [1, 6] |
| GART | Purine biosynthesis enzyme | De novo purine pathway research [1, 6] |
| MTHFD2 | One-carbon metabolism enzyme supporting nucleotide synthesis | Cancer metabolism and dNTP supply studies [1, 6] |
| SHMT2 | Serine hydroxymethyltransferase, supports one-carbon and nucleotide synthesis | Mitochondrial nucleotide metabolism research [1, 6] |
How Is 2'-deoxyribonucleotide biosynthetic process Regulated?
2'-Deoxyribonucleotide biosynthesis is regulated at multiple levels to match dNTP supply with DNA replication demand [1, 8]. Ribonucleotide reductase activity is controlled by allosteric feedback and cell cycle-dependent expression, while salvage kinases are regulated by substrate availability and post-translational modifications [1, 6]. SAMHD1 and related factors help maintain balanced dNTP pools and can restrict viral replication when pools are perturbed [1, 8]. Oxidative stress and lipid peroxidation-derived aldehydes can modify 2'-deoxyribonucleotides, adding another layer of regulation and damage surveillance [4, 8].
2'-deoxyribonucleotide biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RRM1 | Cancer drug resistance and dNTP pool regulation | Knockout or point-mutation cell lines with dNTP profiling [1, 6] |
| TYMS | Fluoropyrimidine sensitivity and thymidylate imbalance | Knockout and overexpression models for drug response [1, 6] |
| TK2 | Mitochondrial DNA depletion syndrome | Knock-in or knockout models for mitochondrial dNTP pools [1, 8] |
| DGUOK | Mitochondrial DNA depletion and liver disease | Patient-derived or CRISPR knockout cell models [1, 8] |
| SAMHD1 | Viral restriction and dNTP pool control | Knockout and tagged knock-in for interaction studies [1, 8] |
Cancer and nucleotide metabolism
Cancer cells often increase deoxyribonucleotide biosynthesis to support rapid proliferation, making enzymes such as RRM1, RRM2, and TYMS attractive therapeutic targets [1, 6]. Imbalanced dNTP pools can also promote mutagenesis and replication stress, contributing to tumor evolution [1, 8]. Nucleoside analogs that require salvage kinases for activation are widely used in chemotherapy, linking GO:0009265 directly to drug response [1, 6].
Mitochondrial DNA depletion syndromes
Defects in mitochondrial deoxyribonucleoside salvage enzymes, including TK2 and DGUOK, impair mitochondrial DNA maintenance and cause mitochondrial DNA depletion syndromes [1, 8]. These disorders highlight the importance of balanced 2'-deoxyribonucleotide pools outside the nucleus [1, 8]. Experimental models with altered salvage enzyme activity help define tissue-specific nucleotide requirements [1, 6].
Viral infection and antiviral therapy
Viruses depend on host 2'-deoxyribonucleotide biosynthesis and salvage for genome replication, and several antiviral drugs are modified 2'-deoxyribonucleotide analogs [2, 6]. Herpes primase interactions with nucleotide sugars have been studied to understand how viral replication enzymes recognize substrates. Modified 2'-deoxyribonucleotides can inhibit viral polymerases and provide templates for drug design [2, 6].
Oxidative stress and DNA damage
Oxidized 2'-deoxyribonucleotides, such as 8-oxo-7,8-dihydro-2'-deoxyguanosine, are markers of oxidative DNA damage and are processed by repair pathways. Mass spectrometry methods have been developed to detect 2'-deoxyribonucleotide adducts formed with lipid peroxidation-derived aldehydes. These measurements connect GO:0009265 to oxidative stress biology and nucleotide excision repair [4, 8].
From 2'-deoxyribonucleotide biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for de novo dNTP synthesis? | CRISPR knockout cell line with dNTP measurement [1, 6] |
| Does a specific catalytic residue control enzyme activity? | Point-mutation knock-in cell line [1, 6] |
| How does a disease-associated variant affect nucleotide pools? | Knock-in of the variant allele [1, 8] |
| Where and when is the protein expressed? | Tagged knock-in with imaging or proteomics [1, 6] |
| Does overexpression drive proliferation or drug resistance? | Doxycycline-inducible overexpression model [1, 6] |
| Which genes are synthetic lethal with pathway loss? | CRISPR library screening and bioinformatics [1, 6] |
How to Study the 2'-deoxyribonucleotide biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS nucleotide profiling | Levels of 2'-deoxyribonucleotides and adducts | dNTP pool analysis after gene perturbation [1, 4] |
| Enzyme activity assay | Catalytic activity of nucleotide synthesis enzymes | Validation of RRM1, TYMS, or kinase function [1, 6] |
| DNA polymerase incorporation assay | Substrate use of modified 2'-deoxyribonucleotides | Analog evaluation for therapeutics [2, 6] |
| CRISPR knockout screening | Gene requirement for growth or drug sensitivity | Discovery of pathway vulnerabilities [1, 6] |
| RNA-seq | Transcriptional changes in nucleotide metabolism genes | Pathway response to stress or treatment [1, 6] |
| Proteomics | Protein expression and interactions | Mapping enzyme complexes in nucleotide synthesis [1, 6] |
| Imaging with tagged knock-in | Subcellular localization of pathway enzymes | Compartment-specific dNTP synthesis studies [1, 6] |
| Metabolomics | Global metabolite changes including nucleotides | Systems-level analysis of GO:0009265 [1, 6] |
Nucleotide pool quantification
Mass spectrometry-based methods can quantify 2'-deoxyribonucleoside and 2'-deoxyribonucleotide levels, including aldehyde adducts formed during lipid peroxidation. These measurements are essential for linking gene perturbation to changes in GO:0009265 output [1, 4]. Isotope tracing can further distinguish de novo synthesis from salvage [1, 6].
Enzyme activity assays
Recombinant enzymes or cell lysates can be used to measure ribonucleotide reductase, thymidylate synthase, and deoxyribonucleoside kinase activities [1, 6]. Synthetic 2'-modified nucleotides serve as substrates or inhibitors to probe enzyme specificity [2, 6]. Such assays help validate whether a gene product directly acts in 2'-deoxyribonucleotide biosynthesis [1, 6].
DNA polymerase substrate testing
Modified 2'-deoxyribonucleotides can be tested as substrates for DNA polymerases to determine how chemical changes affect incorporation. This approach is used to evaluate nucleotide analogs for antiviral and anticancer applications [2, 6]. It also provides mechanistic insight into how polymerases discriminate among nucleotides.
CRISPR screening and bioinformatics
Genome-wide CRISPR knockout or activation screens can identify genes that modify sensitivity to nucleotide-targeting drugs or dNTP pool stress [1, 6]. Bioinformatics analysis of screen data helps prioritize pathway components for validation [1, 6]. Integrating screening with metabolomics and transcriptomics provides a systems view of GO:0009265 regulation [1, 6].
How CRISPR Can Be Used to Study GO:0009265 2'-deoxyribonucleotide biosynthetic process
Knockout
CRISPR knockout of genes such as RRM1, RRM2, TYMS, or DCK can reveal whether they are required for 2'-deoxyribonucleotide biosynthesis and cell proliferation [1, 6]. Knockout models are useful for measuring dNTP pool changes and sensitivity to nucleoside analogs [1, 6]. They also help distinguish essential from redundant salvage routes [1, 6].
Point Mutation
Point-mutation knock-in can test specific catalytic residues or disease-associated variants in nucleotide synthesis enzymes [1, 6]. Such models separate catalytic activity from scaffolding or regulatory functions [1, 6]. They are especially valuable when complete knockout causes lethality or confounding developmental effects [1, 6].
Knock-in
Knock-in of tagged or variant alleles allows precise tracking of enzyme localization, interactions, and stability [1, 6]. Disease-relevant variants in genes such as TK2 or DGUOK can be introduced to model mitochondrial nucleotide defects [1, 8]. Knock-in reporters can also be used to monitor pathway activity in live cells [1, 6].
Overexpression
Overexpression of rate-limiting enzymes can increase 2'-deoxyribonucleotide production and drive proliferation or drug resistance [1, 6]. Inducible overexpression systems allow controlled testing of dose-dependent effects on dNTP pools [1, 6]. These models complement loss-of-function studies to establish causality [1, 6].
How EDITGENE Supports 2'-deoxyribonucleotide biosynthetic process Research
Researchers studying 2'-deoxyribonucleotide biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide supply, DNA replication, or drug response. EDITGENE provides CRISPR-based cell models and screening services that enable precise, reproducible testing of genes in GO:0009265 and related pathways [1, 6].
Contact EDITGENE today to design your custom CRISPR model for 2'-deoxyribonucleotide biosynthetic process research.
Frequently Asked Questions About 2'-deoxyribonucleotide biosynthetic process
What is GO:0009265?
GO:0009265 is the Gene Ontology term for 2'-deoxyribonucleotide biosynthetic process, the set of reactions that produce phosphorylated 2'-deoxyribonucleotides for DNA synthesis [1, 4].
What is the definition of 2'-deoxyribonucleotide biosynthetic process?
It is the chemical reactions and pathways resulting in the formation of a 2'-deoxyribonucleotide, a base linked to a 2'-deoxyribose sugar and esterified with a phosphate group [1, 4].
What genes are involved in 2'-deoxyribonucleotide biosynthetic process?
Key genes include RRM1, RRM2, TYMS, DCK, TK1, TK2, DGUOK, NME1, NME2, and SAMHD1, among others [1, 6].
Why is 2'-deoxyribonucleotide biosynthesis important for DNA replication?
It supplies the dNTP building blocks that DNA polymerases require to copy and repair the genome [1, 4].
How are 2'-deoxyribonucleotides synthesized?
They are made by de novo reduction of ribonucleotides and by salvage phosphorylation of deoxyribonucleosides [1, 6].
What diseases are linked to defects in 2'-deoxyribonucleotide metabolism?
Cancer, mitochondrial DNA depletion syndromes, and viral infections are linked to altered 2'-deoxyribonucleotide metabolism [1, 8].
How can CRISPR be used to study 2'-deoxyribonucleotide biosynthesis?
CRISPR knockout, point-mutation, knock-in, and overexpression models can test causal roles of pathway genes and their variants [1, 6].
What methods measure 2'-deoxyribonucleotide levels?
LC-MS/MS and related mass spectrometry methods quantify 2'-deoxyribonucleotides and their adducts [1, 4].
Are modified 2'-deoxyribonucleotides useful in therapy?
Yes, 2'-modified nucleotides and nucleoside analogs are used as antiviral and anticancer agents and as polymerase substrates [2, 6].
What is the role of ribonucleotide reductase in GO:0009265?
Ribonucleotide reductase catalyzes the rate-limiting reduction of ribonucleotides to 2'-deoxyribonucleotides [1, 6].
Conclusion
GO:0009265, 2'-deoxyribonucleotide biosynthetic process, is a central metabolic process that supplies the building blocks for DNA replication and repair [1, 4]. Its enzymes and regulatory nodes are linked to cancer, mitochondrial disease, viral infection, and drug response, making it a rich area for functional genomics [1, 8]. CRISPR-based knockout, point-mutation, knock-in, overexpression, and screening models provide powerful tools to test causality and identify new therapeutic opportunities in this pathway [1, 6].
References
- 1. Laine T et al.. 2025. Chondroitin Sulfate-Coated Heteroduplex-Molecular Spherical Nucleic Acids.. Chembiochem 26(6):e202400908 PMID: 39544138
- 2. Pagratis NC et al.. 1997. Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor.. Nat Biotechnol 15(1):68-73 PMID: 9035109
- 3. Keller KE et al.. 2008. Interaction of herpes primase with the sugar of a NTP.. Biochemistry 47(34):8977-84 PMID: 18672908
- 4. Doerge DR et al.. 1998. Mass spectrometric analysis of 2-deoxyribonucleoside and 2'-deoxyribonucleotide adducts with aldehydes derived from lipid peroxidation.. Rapid Commun Mass Spectrom 12(22):1665-72 PMID: 9853382
- 6. Dutson C et al.. 2021. Synthesis of Polyanionic C5-Modified 2'-Deoxyuridine and 2'-Deoxycytidine-5'-Triphosphates and Their Properties as Substrates for DNA Polymerases.. Molecules 26(8) PMID: 33924626
- 8. Evans MD et al.. 2016. Nucleotide excision repair of oxidised genomic DNA is not a source of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine.. Free Radic Biol Med 99:385-391 PMID: 27585947
